Abstract
HIV transmission through heterosexual contact remains the greatest risk factor for women globally. Topical microbicides applied intravaginally may offer a female-initiated HIV prevention option for many who are unable or unwilling to use male condoms or who would want additional protection. This article presents results of focus groups in Bridgeport, Connecticut, Providence, Rhode Island, and San Juan, Puerto Rico, with women who use crack or heroin or have male partners who inject illegal drugs. Participants revealed motivation for and openness to using microbicides effective against HIV should they become available. Additional lubrication during intercourse was one of several expected positive features of microbicides; women saw lubrication as a means of enhancing pleasure and reducing condom irritation and breakage while also protecting them from infection. Conversely, some women feared that their male partners would interpret excessive lubrication as an indication of infection, improper hygiene, or evidence of sex with another man. Focus groups also provided insight into how aspects of different women's sexual lives, including partner type, might influence the issues that would concern them if and when they tried out new microbicidal products in the future.
Similar content being viewed by others
References
Abdool Karim, K., and Zuma, N. D. (1993). Prevention of HIV infection for women by women in Natal, South Africa, Durban. Preliminary findings, ICRW: Women and AIDS Program. Durban, South Africa: Research Institute for Diseases in a Tropical Environment.
Astemborski, J., Vlahov, D., Warren, D., Solomon, L., and Nelson, K. E. (1994). The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. American Journal of Public Health, 84, 382–387.
Baleta, A. (1998). Concern voiced over “dry sex” practices in South Africa. Lancet, 352, 1292.
Bentley, M. E., Morrow, K., Fullem, A., Chesney, M., Horton, S., Rosenberg, Z., and Mayer, K. H. (2000). Acceptability of a novel vaginal microbicide during Phase 1 safety trial among low-risk women. Family Planning Perspectives, 32, 184–188.
Blanchard, K., Coggins, C., Friedland, B., and van Wijgert, J. (1998). Men's attitudes toward vaginal products: A three-country study. New York: Population Council.
Brown, J. E., Ayowa, O. B., and Brown, R. (1993). Dry and tight: Sexual practices and potential AIDS risk in Zaire. Social Science and Medicine, 37, 989–994.
Centers for Disease Control and Prevention (1996). Contraceptive method and condom use among women at risk for HIV infection and other sexually transmitted diseases–Selected U.S. sites, 1993–1994. Morbidity and Mortality Weekly Report, 45, 820.
Centers for Disease Control and Prevention (2000). HIV/AIDS Surveillance Report, 12, 14.
Centers for Disease Control and Prevention (2001). HIV/AIDS Surveillance Report, 13, 14.
Chesney, M., Bentley, M. E., Morrow, K. M., and Mayer, K. (1998, June). Real experience: The key to microbicide acceptability. Poster session presented at the 12th World AIDS Conference, Geneva.
Civic, D., and Wilson, D. (1996). Dry sex in Zimbabwe and implications for condom use. Social Science and Medicine, 42, 91–98.
References regarding the formulation of over-the-counter vaginal spermicides. Critical issues in reproductive health. New York: Population Council.
Darroch, J. E., and Frost, J. J. (1999). Women's interest in vaginal microbicides. Family Planning Perspectives, 31, 16–23.
de Zoysa, I., Elias, C. J., and Bentley, M. (1998). Ethical challenges in efficacy trials of vaginal microbicides for HIV prevention. American Journal of Public Health, 88, 571–575.
Elias, C., and Coggins, C. (1996). Female-controlled methods to prevent sexual transmission of HIV. AIDS, 10 (Suppl. 3), S43–S51.
Elias, C., and Coggins, C. (2001). Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going? Journal of Women's Health and Gender-Based Medicine, 10, 163–173.
Elias, C. J., and Heise, L. (1994). Challenges for the development of female-controlled vaginal microbicides. AIDS, 8, 1–9.
Exner, T. M., Seal, D. W., and Ehrhardt, A. A. (1997). A review of HIV interventions for at-risk women. AIDS and Behavior, 1, 93–124.
Gollub, E. L. (1995). Women-centered prevention techniques and technologies. In A. O'Leary and L. S. Jemmott (Eds.), Women at risk: Issues in the primary prevention of AIDS (pp. 43-82). New York: Plenum Press.
Gollub, E. L. (1999). Human rights is a US problem, too: The case of women and HIV. American Journal of Public Health, 89, 1479–1482.
Gollub, E. (2000). The female condom: Tool for women's empowerment. American Journal of Public Health, 90, 1377.
Gollub, E. L., Stein, Z., and El-Sadr, W. (1995). Short-term acceptability of the female condom among staff and patients at a New York City hospital. Family Planning Perspectives, 27, 155–158.
Gross, M., Buchbinder, S., Celum, C., Hagerty, P., and Seage, G. (1998). Rectal microbicides for gay men. Are clinical trials needed? Are they feasible? Sexually Transmitted Diseases, 25, 296–302.
Hammett, T., Mason, T., Joanis, C., Foster, S., Harmon, P., Robles, R., Finlanson, A., Feudo, R., Vining-Bethea, S., Jeter, G., Mayer, K., Dougherty-Iddings, P., and Seage, G. (2000a). Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: Results of product trials in three cities. Sexually Transmitted Diseases, 27, 119–126.
Hammett, T., Norton, G., Mason, T., Langenbahn, S., Mayer, K., Robles, R., Feudo, R., and Seage, G. (2000b). Drug-involved women as potential users of vaginal microbiocides for HIV and SID prevention: A three-city survey. Journal of Women's Health and Gender-Based Medicine, 9, 1071–1080.
Harrison, P. F. (2002). Products in the pipeline: Overview, change, lessons and implications. Paper presented at Microbicides 2002, Antwerp, Belgium.
Heise, L. (1997). Beyond acceptability: Reorienting research on contraceptive choice. In T. K. Sundari Ravindran, M. Berer, and J. Cottingham (Eds.). Beyond acceptability: Users' perspectives on contraception. London: Reproductive Health Matters, for the World Health Organization.
Heise, L., and Elias, C. (1994). Transforming AIDS prevention to meet women's needs: A focus on developing countries. Social Science and Medicine, 40, 931–943.
Hira, S., Spruyt, A., Feldblum, P., Sankutu, M. R., Glover, L. H., and Steiner, M. J. (1995). Spermicide acceptability among patients at a sexually transmitted disease clinic in Zambia. American Journal of Public Health, 85, 1098–1103.
Jones, D. L., Weiss, S. M., Malon, R., Ishii, M., Devieux, J., Stanley, H., Cassels, A., Tobon, J. N., Brondolo, E., LaPerriere, A., Efantis-Potter, J., O'Sullivan, M., and Schneiderman, N. (2001). A brief sexual barrier intervention for women living with AIDS: Acceptability, use, and ethnicity. Journal of Urban Health, Bulletin of the New York Academy of Medicine, 78, 593–604.
Keller, A. (1979). Contraceptive acceptability research: Utility and limitations. Studies in Family Planning, 10, 230–237.
Latka, M. (2001). Female-initiated barrier methods for the prevention of STI/HIV: Where are we now? Where should we go? Journal of Urban Health, Bulletin of the New York Academy of Medicine, 78, 571–580.
Mantell, J. E., Hoffman, S., Weiss, E., Adeokun, L., Delano, G., Jagna, T., Exner, T. M., Stein, Z. A., Abdool Karim, Q., Scheepers, E., Atkins, K., and Weiss, E. (2001). The acceptability of the female condom: Perspectives of family planning providers in New York City, South Africa, and Nigeria. Journal of Urban Health, Bulletin of the New York Academy of Medicine, 78, 658–668.
Moon, M. W., Khumalo-Sakutukwa, G. N., Heiman, J. E., Mbizvo, M. T., and Padian, N. S. (2002). Vaginal microbicides for HIV/STI prevention in Zimbabwe: What key informants say. Journal of Transcultural Nursing, 13, 19–23.
Morrow, K., Rosen, R. K., Richter, L., Emans, A., Forbes, A., Day, J., Shagan, N., Maslankowski, L., Profy, A. T., Kelly, C., Abdool Karim, S. S., and Mayer, K. (2002). The acceptability of an investigational vaginal microbicide agent, Pro2000 gel. Poster presented at Microbicides 2002, Antwerp, Belgium.
Morrow, K. M., Rosen, R. R., Richter, L., Emans, A., Forbes, A., Day, J., Morar, N., Maslankowski, L., Profy, A. T., Kelly, C., Abdool Karim, S. S., and Mayer, K. H. (2003). The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, in the context of a Phase I clinical trial. Manuscript submitted for publication.
Pool, R. (1999). Acceptability of the female condom and vaginal spermicidal products in Uganda. Sexual Health Exchange, 1, 5–7.
Pool, R., Hart, G., Green, G., Harrison, S., Nyanzi, S., and Whitworth, J. (2000). Men's attitudes to condoms and female controlled means of protection against HIV and STDs in south-western Uganda. Culture, Health and Sexuality, 2, 197–211.
Rosenthal, S. L., Cohen, S. S., and Stanberry, L. R. (1998). Topical microbicides: Current status and research considerations for adolescent girls. Sexually Transmitted Diseases, 25, 368–377.
Sokal, D. C., and Hermonat, P. L. (1995). Priorities for vaginal microbicide research. American Journal of Public Health, 185, 737–738.
Stein, Z. A. (1993). HIV prevention: An update on the status of methods women can use. Editorial. American Journal of Public Health, 83, 1379–1382.
Stein, Z. A. (1994). What was new at Yokohama: Women's voices at the 1994 International AIDS conference. American Journal of Public Health, 84, 1887–1888.
Steiner, M., Spruyt, A., Joanis, C., Glover, L., Cordero, M., Alvarado, G., and Onoka, C. (1995). Acceptability of spermicidal film and foaming tablets among women in three countries. International Family Planning Perspectives, 21, 104–107.
Steiner, M., Glover, L., Bou-Saada, I., and Piedrahita, C. (1998). Increasing barrier method use among oral contraceptive users at risk of STDs: What approach is best? Sexually Transmitted Disease, 25, 139.
Stevens, S. J., Estrada, A., and Estrada, B. D. (1998). HIV, sex and drug risk behavior and behavior change in a national sample of injection drug and crack cocaine using women. In S. J. Stevens, S. Tortu, and S. L. Coyle (Eds.), Women, drug use and HIV infection (pp. 25-47). New York: The Haworth Press, Inc.
Stone, A. B., and Hitchcock, P. J. (1994). Vaginal microbicides for preventing the sexual transmission of HIV. AIDS, 8(Suppl. 1): S285-S293.
Strauss, A., and Corbin, J. (1990). Basics of qualitative research: grounded theory procedures and techniques. Newbury Park, CA: Sage.
Tortu, S., Beardsley, M., Deren, S., Williams, M., and McCoy, H. V., Stark, M., Estrada, A., and Goldstein, M. (2000). HIV Infection and patterns of risk among women drug injectors and crack users in low and high sero-prevalence sites. AIDS Care, 12, 65-76
Wood, M. M., Tortu, S., Rhodes, F., and Deven, S. (1998). Differences in condom behaviors and beliefs among female drug users recruited in two cities. Women's Health, 27, 137.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mason, T.H., Foster, S.E., Finlinson, H.A. et al. Perspectives Related to the Potential Use of Vaginal Microbicides Among Drug-Involved Women: Focus Groups in Three Cities in the United States and Puerto Rico. AIDS Behav 7, 339–351 (2003). https://doi.org/10.1023/B:AIBE.0000004726.61630.96
Issue Date:
DOI: https://doi.org/10.1023/B:AIBE.0000004726.61630.96